国际英语新闻:Thailand's state of emergency unlikely to extend after end of May
BANGKOK, May 11 (Xinhua) -- The National Security Council (NSC) told the media on Monday that it is highly likely that Thailand's State of Emergency will end on May 31.
The NSC's secretary-general Gen. Somsak Roongsita said that the National Intelligence Agency (NIA) and the Internal Security Operations Command (ISOC) had conducted studies and surveys during the lockdown period.
"Both agencies were quite satisfied with the overall public health and safety situations," said Somsak.
"The NIA and ISOC also acknowledged the dwindling number of the daily new COVID-19 infections and believed that the general Thais have good understandings of the need to social distance at the time of the pandemic outbreak," said Somsak.
"It is highly likely that the emergency decree will not be extended after May 31," said Somsak.
The decree authorizes Thai Prime Minister Prayut Chan-o-cha to give orders to fight the virus, with the supreme commander of the armed forces, ministers of public health, interior, commerce and foreign affairs to assist him.
Thailand's new COVID-19 cases are on a downward trend. On Monday, the Ministry of Public Health reported six new COVID-19 cases, bringing the cumulative total to 3,015.
No new fatalities were reported.
相关文章
- 欧美文化:Emergency rooms see more gun violence victims in U.S. in 1st year of pandemic: CNN
- 欧美文化:Sri Lankan military authorized to maintain law, order amid unrest
- 欧美文化:Russian FM visits Algeria to mark 60th anniversary of ties
- 欧美文化:Spanish government sacks spy chief after phone tapping scandal
- 欧美文化:Turkey, Kazakhstan aim to reach 10 bln USD in bilateral trade: president
- 欧美文化:Moroccan, Egyptian FMs discuss prospects of bolstering cooperation
- 欧美文化:Macron visits Berlin on first foreign trip after re-election
- 欧美文化:Serbia, China commemorate journalists killed in NATO bombing 23 years ago
- 欧美文化:Israel celebrates 74th Independence Day
- 欧美文化:U.S. FDA limits use of Johnson & Johnson COVID-19 vaccine over blood clot risk